Biosergen
0.428
SEK
+9.46 %
Less than 1K followers
BIOSGN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+9.46%
-2.28%
-19.25%
-34.95%
-36.5%
-0.47%
-84.33%
-
-88.42%
Biosergen is a biotechnology company. The company specializes in the research and development of various pharmaceuticals. The product portfolio includes, for example, the company's product BSG005, a fungicidal pharmaceutical in the clinical phase. In addition to the main business, service and associated ancillary services are also offered. The company operates in Norway. Biosergen was founded in 2004 and is headquartered in Solna.
Read moreMarket cap
100.5M SEK
Turnover
99.61K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
21.5
2025
Interim report Q1'25
11.6
2025
General meeting '25
20.8
2025
Interim report Q2'25
ShowingAll content types
Biosergen AB: BioStock: Biosergen scales up for future wins
Biosergen AB: Biosergen publishes interim report for fourth quarter 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools